Clinical Trial Update: MA-CRC-II-016 SHR-1811 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for SHR-1811 (MA-CRC-II-016) in metastatic colorectal cancer with HER2. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• SHR-1811

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: mCRC, HER2 | Phase 2 | Status: NOT_YET_RECRUITING